Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness
Denisa Ferastraoaru, Golda Hudes, Elina Jerschow, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 3, pp. 1152-1162.e3
Open Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

Sex and gender in asthma
Nowrin U. Chowdhury, Vamsi P. Guntur, Dawn C. Newcomb, et al.
European Respiratory Review (2021) Vol. 30, Iss. 162, pp. 210067-210067
Open Access | Times Cited: 264
Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19
Daniel Munblit, Polina Bobkova, Ekaterina Spiridonova, et al.
Clinical & Experimental Allergy (2021) Vol. 51, Iss. 9, pp. 1107-1120
Open Access | Times Cited: 168
Advances and highlights in biomarkers of allergic diseases
İsmail Öğülür, Yağız Pat, Özge Ardıçlı, et al.
Allergy (2021) Vol. 76, Iss. 12, pp. 3659-3686
Open Access | Times Cited: 150
Asthma and COVID-19 risk: a systematic review and meta-analysis
Anthony Paulo Sunjaya, S. Allida, Gian Luca Di Tanna, et al.
European Respiratory Journal (2021) Vol. 59, Iss. 3, pp. 2101209-2101209
Open Access | Times Cited: 99
Asthma and COVID-19: an update
Yochai Adir, Walid Saliba, Antoine Beurnier, et al.
European Respiratory Review (2021) Vol. 30, Iss. 162, pp. 210152-210152
Open Access | Times Cited: 89
COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence
Yochai Adir, Marc Humbert, Walid Saliba
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 2, pp. 361-367.e13
Open Access | Times Cited: 74
Asthma phenotypes, associated comorbidities, and long‐term symptoms in COVID‐19
L. Eggert, Ziyuan He, William Collins, et al.
Allergy (2021) Vol. 77, Iss. 1, pp. 173-185
Open Access | Times Cited: 65
Eosinophils as potential biomarkers in respiratory viral infections
Iole Macchia, Valentina La Sorsa, Francesca Urbani, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28
Eosinophils and COVID-19: diagnosis, prognosis, and vaccination strategies
Helene F. Rosenberg, Paul S. Foster
Seminars in Immunopathology (2021) Vol. 43, Iss. 3, pp. 383-392
Open Access | Times Cited: 55
Estimating COVID-19 Infection and Severity Risks in Patients with Chronic Rhinosinusitis: A Korean Nationwide Cohort Study
Seung Won Lee, So Young Kim, Sung Yong Moon, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 6, pp. 2262-2271.e2
Open Access | Times Cited: 54
Asthma and COVID-19: a dangerous liaison?
Carlo Lombardi, Federica Gani, Alvise Berti, et al.
Asthma Research and Practice (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 46
Innate Immune Responses by Respiratory Viruses, Including Rhinovirus, During Asthma Exacerbation
Kazuyuki Nakagome, Makoto Nagata
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Comorbidities, Associated Diseases, and Risk Assessment in COVID-19—A Systematic Review
Andreea Fitero, Simona Bungău, Delia Mirela Ţiţ, et al.
International Journal of Clinical Practice (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 33
Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview
Igor Kudryavtsev, Artem Rubinstein, А. С. Головкин, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 1082-1082
Open Access | Times Cited: 31
Epidemiology, Healthcare Resource Utilization, and Mortality of Asthma and COPD in COVID-19: A Systematic Literature Review and Meta-Analyses
David Halpin, Adrian Paul J. Rabe, Wei Jie Loke, et al.
Journal of Asthma and Allergy (2022) Vol. Volume 15, pp. 811-825
Open Access | Times Cited: 29
Risk factors for long-term consequences of COVID-19 in hospitalised adults in Moscow using the ISARIC Global follow-up protocol: StopCOVID cohort study
Daniel Munblit, Polina Bobkova, Ekaterina Spiridonova, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 39
The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19
Yadong Gao, Ioana Agache, Mübeccel Akdiş, et al.
International Immunology (2021) Vol. 34, Iss. 4, pp. 177-188
Open Access | Times Cited: 39
Eosinophils and Bacteria, the Beginning of a Story
Edna Ondari, Esther Calvino-Sanles, Nicholas J. First, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8004-8004
Open Access | Times Cited: 36
Does airborne pollen influence COVID-19 outbreak?
Khaiwal Ravindra, Akshi Goyal, Suman Mor
Sustainable Cities and Society (2021) Vol. 70, pp. 102887-102887
Open Access | Times Cited: 35
Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease
Ricarda Cortés-Vieyra, Sergio Gutiérrez‐Castellanos, Cleto Álvarez-Aguilar, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1675-1675
Open Access | Times Cited: 33
Chronic Rhinosinusitis and COVID-19
Concepció Marı́n, Thomas Hummel, Zheng Liu, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 6, pp. 1423-1432
Open Access | Times Cited: 27
Eosinophilia Is Associated with Improved COVID-19 Outcomes in Inhaled Corticosteroid-Treated Patients
Joe Zein, Ronald A. Strauss, Amy Attaway, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 3, pp. 742-750.e14
Open Access | Times Cited: 24
The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy
Aliakbar Hasankhani, Abolfazl Bahrami, Bahareh Tavakoli‐Far, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Exploring Asthma as a Protective Factor in COVID-19 Outcomes
Anthony E. Quinn, Lei Zhao, Scott D. Bell, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1678-1678
Open Access
Relationship of eosinophil level with severe COVID-19 outcomes in asthma of the elderly
A. A. Pozdniakova, V. V. Gaynitdinova, З. М. Мержоева, et al.
Journal of Respiratory Medicine (2025) Vol. 1, Iss. 1, pp. 5-5
Closed Access
Page 1 - Next Page

Scroll to top